EDITOR
	Neil Love, MD Medical Oncologist Editor, Breast Cancer Update for Nurses Research To Practice Miami, Florida
FACULTY AFFILIATIONS
	Joseph A Sparano, MD Professor of Medicine and Women’s Health Albert Einstein College of Medicine Associate Chairman, Department of Oncology Montefiore Medical Center Director, Breast Evaluation Center Montefiore-Einstein Cancer Center Bronx, New York		Fredrica Preston, RNC, NP Nurse Practitioner North Shore Cancer Center Peabody, Massachusetts
	Daniel R Budman, MD Associate Chief Don Monti Division of Medical Oncology Division of Hematology North Shore University Hospital Professor of Medicine New York University Manhasset, New York		Robert Livingston, MD Professor of Medicine, Oncology Arizona Cancer Center Tucson, Arizona

CONTENT VALIDATION AND DISCLOSURES

Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CNE activities. Real or apparent conflicts of interest are identified and resolved by a peer review content validation process. The content of each activity is reviewed by both a member of the scientific staff and an external, independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

The scientific staff and consultants for Research To Practice are involved in the development and review of content for educational activities and report the following real or apparent conflicts of interest for themselves (or their spouses/partners) that have been resolved through a peer review process: John H Brebner, Richard Kaderman, PhD, Joanne Librie, RN, Neil Love, MD, Anne O’Connor, RN, MSN, AOCN, Douglas Paley, Margaret Peng, Lilliam Sklaver Poltorack, PharmD, Ginelle Suarez, Jean Treacy, RN, CS, AOCNP, Erin Wall and Kathryn Ault Ziel, PhD — no real or apparent conflicts of interest to report; Sally Bogert, RNC, WHCNP — shareholder of Amgen Inc and Genentech BioOncology. Research To Practice receives education grants from Abraxis BioScience, Amgen Inc, AstraZeneca Pharmaceuticals LP, Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Biogen Idec, Genentech BioOncology/OSI Pharmaceuticals Inc, Genomic Health Inc, Roche Laboratories Inc and Sanofi-Aventis, who have no influence on the content development of our educational activities.

In addition, the following faculty (and their spouses/partners) have reported real or apparent conflicts of interest that have been resolved through a peer review process:

Dr Sparano — Consulting Fees: Genentech BioOncology, Sanofi-Aventis. Dr Budman — Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, GlaxoSmithKline, Roche Laboratories Inc, Sanofi-Aventis. Ms Preston — Speakers Bureau: Abraxis BioScience, Amgen Inc, Bristol-Myers Squibb Company, MGI Pharma Inc. Dr Livingston — No financial interests or affiliations to disclose.

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.

Table of Contents

Top of Page